ESTAEstablishment Labs Holdings Inc.

$2B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$44M-9.2% YoY

Gross Profit

$29M65.6% margin

Operating Income

-$9M-21.2% margin

Net Income

-$17M-38.9% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+18.7%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$285M

Total Liabilities

$240M

Stockholders' Equity

$45M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$49M	-9.2%
Gross Profit	$29M	$30M	-4.4%
Operating Income	-$9M	-$14M	+31.9%
Net Income	-$17M	-$17M	-2.6%

Geographic Segments

EMEA

$21M48%

Asia Pacific

$14M32%

Latin America

$9M20%

Other Geographical Areas

$125,0000%

ESTA Q2 2024 Earnings — Establishment Labs Holdings Inc. Revenue & Financial Results | Market Cap Arena